{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T06:19:01Z","timestamp":1783491541194,"version":"3.55.0"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In recent years, a growing number of studies have reported that patients with severe fever with thrombocytopenia syndrome (SFTS)-associated invasive pulmonary aspergillosis (SAPA) patients exhibit a relatively high incidence and mortality rate. However, the conclusions vary considerably and SFTS patients frequently receive immunosuppressive therapies such as corticosteroid therapy, and the influence on the incidence of SAPA remains uncertain. Therefore, this study intends to conduct a comprehensive systematic review and meta-analysis to consolidate existing evidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Effect estimates were expressed as incidence of SAPA, odds ratio (OR) and 95% confidence intervals (CI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      According to the search strategy, a comprehensive search was carried out in the PubMed, Web of Science, and Embase databases. After a detailed assessment, 10 articles met the inclusion criteria and were included in this study. The results indicate that the incidence of SAPA in SFTS patients is 27.4% (95% CI: 18.9\u201335.9%, I\n                      <jats:sup>2<\/jats:sup>\n                      \u202f=\u202f95.60%). The mortality risk among SAPA patients was significantly higher than that among non-SAPA patients: OR\u202f=\u202f5.381 (95% CI: 3.666\u20137.899, I\n                      <jats:sup>2<\/jats:sup>\n                      \u202f=\u202f0.00%). Therapies including corticosteroid (OR\u202f=\u202f3.104, 95% CI: 2.410\u20133.998, I\n                      <jats:sup>2<\/jats:sup>\n                      \u202f=\u202f35.70%), intravenous immunoglobulin (IVIG) (OR\u202f=\u202f3.952, 95% CI: 1.876\u20138.326, I\n                      <jats:sup>2<\/jats:sup>\n                      \u202f=\u202f77.70%), antibiotics (OR\u202f=\u202f16.419, 95% CI: 8.489\u201331.756), and mechanical ventilation (OR\u202f=\u202f6.456, 95% CI: 4.362\u20139.554, I\n                      <jats:sup>2<\/jats:sup>\n                      \u202f=\u202f43.80%,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.169) are associated with higher odds of SAPA.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study indicates that the incidence of SAPA and the associated mortality risk are relatively high. Moreover, therapies including corticosteroids, IVIG, antibiotics, and mechanical ventilation are associated with higher odds of SAPA. Clinicians should maintain a high index of suspicion for SAPA and consider early diagnostic testing and timely antifungal therapy when SAPA is suspected or confirmed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>CRD420261343968.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1834363","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:58:29Z","timestamp":1783490309000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The impact of different therapies on invasive pulmonary aspergillosis in patients with severe fever and thrombocytopenia syndrome: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"14","author":[{"given":"Feng","family":"Hao","sequence":"first","affiliation":[{"name":"Yantai Center for Disease Control and Prevention","place":["Yantai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzi","family":"Wang","sequence":"additional","affiliation":[{"name":"Yantai Center for Disease Control and Prevention","place":["Yantai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Qu","sequence":"additional","affiliation":[{"name":"Penglai Center for Disease Control and Prevention","place":["Yantai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liquan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Penglai Center for Disease Control and Prevention","place":["Yantai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhua","family":"Zhang","sequence":"additional","affiliation":[{"name":"Penglai Center for Disease Control and Prevention","place":["Yantai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Wei","sequence":"additional","affiliation":[{"name":"Penglai Center for Disease Control and Prevention","place":["Yantai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanman","family":"Hu","sequence":"additional","affiliation":[{"name":"College of Public Health, Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[{"name":"Yantai Center for Disease Control and Prevention","place":["Yantai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anmin","family":"Ge","sequence":"additional","affiliation":[{"name":"Penglai Center for Disease Control and Prevention","place":["Yantai, China"]},{"name":"College of Public Health, Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1056\/NEJMoa1010095","article-title":"Fever with thrombocytopenia associated with a novel Bunyavirus in China","volume":"364","author":"Yu","year":"2011","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/s1473-3099(14)70718-2","article-title":"Severe fever with thrombocytopenia syndrome, an emerging tick-borne zoonosis","volume":"14","author":"Liu","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s12250-016-3931-1","article-title":"Current status of severe fever with thrombocytopenia syndrome in China","volume":"32","author":"Zhan","year":"2017","journal-title":"Virol Sin"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijmm.2025.5610","article-title":"Current status of severe fever with thrombocytopenia syndrome in China (review)","volume":"56","author":"Sun","year":"2025","journal-title":"Int J Mol Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e3851","DOI":"10.1093\/cid\/ciaa1561","article-title":"Epidemiology and ecology of severe fever with thrombocytopenia syndrome in China, 2010\u20132018","volume":"73","author":"Miao","year":"2021","journal-title":"Clin Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijid.2014.04.006","article-title":"Ecological niche modeling for predicting the potential risk areas of severe fever with thrombocytopenia syndrome","volume":"26","author":"Du","year":"2014","journal-title":"Int J Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1029\/2025gh001440","article-title":"Short-term effects of meteorological factors on severe fever with thrombocytopenia syndrome incidence in Xinyang, China","volume":"9","author":"Hu","year":"2025","journal-title":"Geohealth"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2520343","DOI":"10.1080\/21505594.2025.2520343","article-title":"Bandavirus Dabieense: a review of epidemiology, clinical characteristics, pathophysiology, treatment and prevention","volume":"16","author":"Peng","year":"2025","journal-title":"Virulence"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s12250-016-3858-6","article-title":"Entry of severe fever with thrombocytopenia syndrome virus","volume":"32","author":"Yuan","year":"2017","journal-title":"Virol Sin"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e0012068","DOI":"10.1371\/journal.pntd.0012068","article-title":"Association of Liver Function and Prognosis in patients with severe fever with thrombocytopenia syndrome","volume":"18","author":"Zhang","year":"2024","journal-title":"PLoS Negl Trop Dis"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"5916","DOI":"10.1002\/jmv.28059","article-title":"Associated microbiota and treatment of severe fever with thrombocytopenia syndrome complicated with infections","volume":"94","author":"Zhang","year":"2022","journal-title":"J Med Virol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/s1473-3099(18)30293-7","article-title":"Epidemiological and clinical features of laboratory-diagnosed severe fever with thrombocytopenia syndrome in China, 2011-17: a prospective observational study","volume":"18","author":"Li","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.jiac.2018.01.005","article-title":"Clinical features of fatal severe fever with thrombocytopenia syndrome that is complicated by invasive pulmonary Aspergillosis","volume":"24","author":"Chen","year":"2018","journal-title":"J Infect Chemother"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1748830","DOI":"10.3389\/fimmu.2025.1748830","article-title":"Characteristics of T-lymphocyte subsets in patients with severe fever with thrombocytopenia syndrome complicated with invasive pulmonary Aspergillosis: a retrospective study","volume":"16","author":"Xu","year":"2025","journal-title":"Front Immunol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"069","DOI":"10.1055\/s-0043-1777769","article-title":"Acute invasive pulmonary Aspergillosis: clinical presentation and treatment","volume":"45","author":"Heylen","year":"2024","journal-title":"Semin Respir Crit Care Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1298050","DOI":"10.3389\/fcimb.2023.1298050","article-title":"The pathogenic and clinical characteristics of severe fever with thrombocytopenia syndrome patients with co-infections","volume":"13","author":"Song","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e70175","DOI":"10.1002\/jmv.70175","article-title":"Risk factors for co-infections in patients with severe fever with thrombocytopenia syndrome","volume":"97","author":"Sun","year":"2025","journal-title":"J Med Virol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"n160","DOI":"10.1136\/bmj.n160","article-title":"Prisma 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1471-2288-14-45","article-title":"Newcastle-Ottawa scale: comparing reviewers' to authors' assessments","volume":"14","author":"Lo","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/jrsm.12","article-title":"A basic introduction to fixed-effect and random-effects models for Meta-analysis","volume":"1","author":"Borenstein","year":"2010","journal-title":"Res Synth Methods"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1093\/cid\/ciz673","article-title":"Invasive pulmonary Aspergillosis in patients with severe fever with thrombocytopenia syndrome","volume":"70","author":"Bae","year":"2020","journal-title":"Clin Infect Dis"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1209705","DOI":"10.3389\/fmicb.2023.1209705","article-title":"The dose-response relationship between smoking and the risk factor for invasive pulmonary Aspergillosis in patients with severe fever with thrombocytopenia syndrome","volume":"14","author":"Dai","year":"2023","journal-title":"Front Microbiol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"576640","DOI":"10.3389\/fimmu.2021.576640","article-title":"Early-warning immune predictors for invasive pulmonary Aspergillosis in severe patients with severe fever with thrombocytopenia syndrome","volume":"12","author":"Hu","year":"2021","journal-title":"Front Immunol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"e70500","DOI":"10.1002\/jmv.70500","article-title":"Evaluation of the efficacy of prophylactic use of Voriconazole against invasive pulmonary Aspergillosis among severe fever with thrombocytopenia syndrome patients in China","volume":"97","author":"Huang","year":"2025","journal-title":"J Med Virol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1038\/s41598-023-28851-2","article-title":"Investigation of predictors for invasive pulmonary Aspergillosis in patients with severe fever with thrombocytopenia syndrome","volume":"13","author":"Song","year":"2023","journal-title":"Sci Rep"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1448710","DOI":"10.3389\/fmicb.2024.1448710","article-title":"Clinical factors associated with invasive pulmonary Aspergillosis in patients with severe fever with thrombocytopenia syndrome: analysis of a 6-year clinical experience","volume":"15","author":"Wang","year":"2024","journal-title":"Front Microbiol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.ijid.2021.02.088","article-title":"Invasive pulmonary Aspergillosis is a frequent complication in patients with severe fever with thrombocytopenia syndrome: a retrospective study","volume":"105","author":"Xu","year":"2021","journal-title":"Int J Infect Dis"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1186\/s12879-025-12218-1","article-title":"Establishment and validation of a nomogram for predicting severe fever with thrombocytopenia syndrome complicated by invasive pulmonary Aspergillosis","volume":"25","author":"Yan","year":"2025","journal-title":"BMC Infect Dis"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e29647","DOI":"10.1002\/jmv.29647","article-title":"Risk factors for invasive pulmonary Aspergillosis in patients with severe fever with thrombocytopenia syndrome: a multicenter retrospective study","volume":"96","author":"Yao","year":"2024","journal-title":"J Med Virol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"20499361211039050","DOI":"10.1177\/20499361211039050","article-title":"Fungal infections in hematopoietic stem-cell transplant patients: a review of epidemiology, diagnosis, and management","volume":"8","author":"Rahi","year":"2021","journal-title":"Ther Adv Infect Dis"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1586\/1744666x.2014.904747","article-title":"Breaking the Mould - novel diagnostic and therapeutic strategies for invasive pulmonary Aspergillosis in the immune deficient patient","volume":"10","author":"Thornton","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens14020170","article-title":"Invasive fungal disease after chimeric antigen receptor-T immunotherapy in adult and pediatric patients","volume":"14","author":"Evangelidis","year":"2025","journal-title":"Pathogens"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/s2213-2600(18)30274-1","article-title":"Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study","volume":"6","author":"Schauwvlieghe","year":"2018","journal-title":"Lancet Respir Med"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"e0009128","DOI":"10.1371\/journal.pntd.0009128","article-title":"Effects of steroid therapy in patients with severe fever with thrombocytopenia syndrome: a multicenter clinical cohort study","volume":"15","author":"Jung","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"e1634","DOI":"10.1093\/cid\/ciaa1298","article-title":"A National Strategy to diagnose coronavirus disease 2019-associated invasive fungal disease in the intensive care unit","volume":"73","author":"White","year":"2021","journal-title":"Clin Infect Dis"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3390\/v13050785","article-title":"Corticosteroids May have negative effects on the Management of Patients with severe fever with thrombocytopenia syndrome: a case-control study","volume":"13","author":"Kawaguchi","year":"2021","journal-title":"Viruses"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ijid.2015.12.009","article-title":"Decreased monocyte subsets and Tlr4-mediated functions in patients with acute severe fever with thrombocytopenia syndrome (Sfts)","volume":"43","author":"Peng","year":"2016","journal-title":"Int J Infect Dis"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s10238-013-0259-0","article-title":"Detection and evaluation of Immunofunction of patients with severe fever with thrombocytopenia syndrome","volume":"14","author":"Sun","year":"2014","journal-title":"Clin Exp Med"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"104807","DOI":"10.1016\/j.ebiom.2023.104807","article-title":"Clinical efficacy of immunoglobulin on the treatment of severe fever with thrombocytopenia syndrome: a retrospective cohort study","volume":"96","author":"Zhang","year":"2023","journal-title":"EBioMedicine"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"e28712","DOI":"10.1002\/jmv.28712","article-title":"Pulmonary infection in patients with severe fever with thrombocytopenia syndrome: a multicentre observational study","volume":"95","author":"Zuo","year":"2023","journal-title":"J Med Virol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"8030","DOI":"10.21037\/jtd-2025-1198","article-title":"Risk and prognostic patterns of viral-associated invasive pulmonary Aspergillosis: impact of corticosteroid and antibiotic exposure in non-neutropenic hosts","volume":"17","author":"Liu","year":"2025","journal-title":"J Thorac Dis"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13613-021-00923-4","article-title":"Risk factors for invasive aspergillosis in ICU patients with COVID-19: current insights and new key elements","volume":"11","author":"Montrucchio","year":"2021","journal-title":"Ann Intensive Care"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"e17571","DOI":"10.1097\/md.0000000000017571","article-title":"Serial analysis of cytokine and chemokine profiles and viral load in severe fever with thrombocytopenia syndrome: case report and review of literature","volume":"98","author":"Fujikawa","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.jiac.2019.01.013","article-title":"Viral load and inflammatory cytokine dynamics associated with the prognosis of severe fever with thrombocytopenia syndrome virus infection: an autopsy case","volume":"25","author":"Nakamura","year":"2019","journal-title":"J Infect Chemother"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.3855\/jidc.19032","article-title":"Can antiviral drugs address the treatment challenges of severe fever with thrombocytopenia syndrome? - a systematic Meta-analysis","volume":"18","author":"Shen","year":"2024","journal-title":"J Infect Dev Ctries"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1834363\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:58:30Z","timestamp":1783490310000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1834363\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":45,"alternative-id":["10.3389\/fpubh.2026.1834363"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1834363","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"article-number":"1834363"}}